NYSE:LDOS

Leidos Stock Forecast, Price & News

$92.00
-2.14 (-2.27 %)
(As of 09/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$91.83
$94.72
50-Day Range
$92.00
$107.11
52-Week Range
$79.15
$113.75
Volume952,379 shs
Average Volume799,813 shs
Market Capitalization$13.02 billion
P/E Ratio18.04
Dividend Yield1.53%
Beta0.88
30 days | 90 days | 365 days | Advanced Chart
Receive LDOS News and Ratings via Email

Sign-up to receive the latest news and ratings for Leidos and its competitors with MarketBeat's FREE daily newsletter.


Leidos logo

About Leidos

Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company's customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.92 out of 5 stars

Aerospace Sector

4th out of 53 stocks

Computer Integrated Systems Design Industry

4th out of 39 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Leidos (NYSE:LDOS) Frequently Asked Questions

Is Leidos a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Leidos in the last year. There are currently 2 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Leidos stock.
View analyst ratings for Leidos
or view top-rated stocks.

What stocks does MarketBeat like better than Leidos?

Wall Street analysts have given Leidos a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Leidos wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Leidos?

Leidos saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 2,070,000 shares, an increase of 26.2% from the August 15th total of 1,640,000 shares. Based on an average daily volume of 693,200 shares, the days-to-cover ratio is currently 3.0 days. Currently, 1.6% of the shares of the stock are sold short.
View Leidos' Short Interest
.

When is Leidos' next earnings date?

Leidos is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for Leidos
.

How were Leidos' earnings last quarter?

Leidos Holdings, Inc. (NYSE:LDOS) released its quarterly earnings data on Tuesday, August, 3rd. The aerospace company reported $1.52 EPS for the quarter, missing the consensus estimate of $1.58 by $0.06. The aerospace company earned $3.45 billion during the quarter, compared to analysts' expectations of $3.38 billion. Leidos had a trailing twelve-month return on equity of 23.24% and a net margin of 5.54%. The business's quarterly revenue was up 18.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.55 earnings per share.
View Leidos' earnings history
.

How has Leidos' stock been impacted by COVID-19?

Leidos' stock was trading at $97.97 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, LDOS stock has decreased by 6.1% and is now trading at $92.00.
View which stocks have been most impacted by COVID-19
.

How often does Leidos pay dividends? What is the dividend yield for Leidos?

Leidos announced a quarterly dividend on Friday, July 30th. Shareholders of record on Wednesday, September 15th will be paid a dividend of $0.36 per share on Thursday, September 30th. This represents a $1.44 annualized dividend and a dividend yield of 1.57%. The ex-dividend date is Tuesday, September 14th. This is a boost from Leidos's previous quarterly dividend of $0.34.
View Leidos' dividend history
.

Is Leidos a good dividend stock?

Leidos pays an annual dividend of $1.44 per share and currently has a dividend yield of 1.53%. The dividend payout ratio of Leidos is 24.70%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Leidos will have a dividend payout ratio of 20.25% next year. This indicates that Leidos will be able to sustain or increase its dividend.
View Leidos' dividend history.

What guidance has Leidos issued on next quarter's earnings?

Leidos updated its FY 2021 earnings guidance on Tuesday, August, 10th. The company provided earnings per share (EPS) guidance of $6.350-$6.650 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.610. The company issued revenue guidance of $13.70 billion-$14.10 billion, compared to the consensus revenue estimate of $13.96 billion.

What price target have analysts set for LDOS?

10 analysts have issued twelve-month target prices for Leidos' shares. Their forecasts range from $109.00 to $125.00. On average, they expect Leidos' share price to reach $115.67 in the next twelve months. This suggests a possible upside of 25.7% from the stock's current price.
View analysts' price targets for Leidos
or view top-rated stocks among Wall Street analysts.

Who are Leidos' key executives?

Leidos' management team includes the following people:
  • Roger A. Krone, Chairman & Chief Executive Officer
  • Christopher R. Cage, Chief Financial Officer
  • Donald Kosiak, Chief Medical Officer
  • Steve Hull, Chief Information Officer & Senior Vice President
  • James F. Carlini, Chief Technology Officer

What is Roger A. Krone's approval rating as Leidos' CEO?

636 employees have rated Leidos CEO Roger A. Krone on Glassdoor.com. Roger A. Krone has an approval rating of 85% among Leidos' employees.

Who are some of Leidos' key competitors?

What other stocks do shareholders of Leidos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Leidos investors own include NVIDIA (NVDA), Lockheed Martin (LMT), The Boeing (BA), AbbVie (ABBV), Johnson & Johnson (JNJ), The Walt Disney (DIS), AT&T (T), Alibaba Group (BABA), CVS Health (CVS) and Intel (INTC).

What is Leidos' stock symbol?

Leidos trades on the New York Stock Exchange (NYSE) under the ticker symbol "LDOS."

Who are Leidos' major shareholders?

Leidos' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.31%), JPMorgan Chase & Co. (8.28%), BlackRock Inc. (7.76%), State Street Corp (3.85%), Price T Rowe Associates Inc. MD (2.74%) and Victory Capital Management Inc. (2.01%). Company insiders that own Leidos stock include David G Fubini, Gary Stephen May, Jonathan W Scholl, Miriam E John and Roy E Stevens.
View institutional ownership trends for Leidos
.

Which institutional investors are selling Leidos stock?

LDOS stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Thompson Siegel & Walmsley LLC, Sumitomo Mitsui Trust Holdings Inc., Millennium Management LLC, Alliancebernstein L.P., Goldman Sachs Group Inc., Wells Fargo & Company MN, and Price T Rowe Associates Inc. MD. Company insiders that have sold Leidos company stock in the last year include David G Fubini, Gary Stephen May, and Miriam E John.
View insider buying and selling activity for Leidos
or view top insider-selling stocks.

Which institutional investors are buying Leidos stock?

LDOS stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Victory Capital Management Inc., Amundi, Balyasny Asset Management LLC, Morgan Stanley, Morgan Stanley, Cooke & Bieler LP, and First Trust Advisors LP.
View insider buying and selling activity for Leidos
or or view top insider-buying stocks.

How do I buy shares of Leidos?

Shares of LDOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Leidos' stock price today?

One share of LDOS stock can currently be purchased for approximately $92.00.

How much money does Leidos make?

Leidos has a market capitalization of $13.02 billion and generates $12.30 billion in revenue each year. The aerospace company earns $628 million in net income (profit) each year or $5.83 on an earnings per share basis.

How many employees does Leidos have?

Leidos employs 39,000 workers across the globe.

Does Leidos have any subsidiaries?

The following companies are subsidiares of Leidos: BECHTEL SAIC COMPANY LLC, Benham Military Communities LLC, Benham/Ellerbe Becket LLC, Dynetics, IMX Medical Management Services Inc, Leidos Arabia Company Limited, Leidos Biomedical Research Inc., Leidos CDM Solutions LLC, Leidos Consulting Engineers Inc., Leidos Cyber Inc., Leidos Engineering LLC, Leidos Europe Limited, Leidos Federal Healthcare Inc., Leidos Global Technology Corporation, Leidos Government Services Inc., Leidos Health Holdings LLC, Leidos Health LLC, Leidos Inc., Leidos Innovations Australia Pty Ltd., Leidos Innovations Corporation, Leidos Innovations Global Inc., Leidos Integrated Technology LLC, Leidos Intermediate Holdings Inc., Leidos Management Systems Designers Inc., Leidos Services Inc., Leidos Supply Limited, Mission Support Alliance LLC, QTC Holdings Inc., QTC Management Inc., QTC Medical Services Inc., Reveal Imaging Technologies Inc., Systems Made Simple Inc., Sytex Inc., The Sytex Group Inc., Varec Holdings Inc., and Varec Inc..

When was Leidos founded?

Leidos was founded in 1969.

What is Leidos' official website?

The official website for Leidos is www.leidos.com.

Where are Leidos' headquarters?

Leidos is headquartered at 1750 PRESIDENTS STREET, RESTON VA, 20190.

How can I contact Leidos?

Leidos' mailing address is 1750 PRESIDENTS STREET, RESTON VA, 20190. The aerospace company can be reached via phone at (571) 526-6000 or via email at [email protected]


This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.